Market Overview:
The global drug eluting balloon for peripheral artery disease market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of peripheral artery diseases, technological advancements in drug eluting balloons, and rising demand for minimally invasive procedures. Based on type, the global drug eluting balloon for peripheral artery disease market is segmented into 3?g/ mm2, 2?g/ mm2, and others. The 3?g/ mm2 segment is expected to account for the largest share of the global market in 2018 owing to its high efficacy and safety profile. Based on application, the global market is segmented into hospitals, ambulatory surgery centers (ASCs), catheterization laboratories (CLs), and others. The hospitals segment accounted for the largest share of the global market in 2017 and is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due To increasing number Of patients with peripheral artery diseases seeking treatment In Hospitals setting .Based On region ,the Global Drug Eluting Balloon For Peripheral Artery Disease Market Is Segmented Into North America ,Latin America Europe Asia Pacific And Middle East & Africa .
Product Definition:
A drug eluting balloon is a type of balloon catheter that is used to open narrowed or blocked blood vessels in the body. The balloon is coated with a drug that helps to keep the vessel open after the balloon has been inflated. This type of catheter may be used to treat peripheral artery disease (PAD), a condition in which narrowed arteries reduce blood flow to the legs and feet.
3?g/ mm2:
3?g/ mm2 is the size of a typical blood vessel and its growth factor is 10.000. It represents that for every millimeter of your body's length, there are around 3 million vessels brancheding off from it.
2?g/ mm2:
A: The average 2?g/ mm2 sized microchips can cover an area of approximately 1 cm2. It is used in the Drug Eluting Balloon (DEB) for peripheral artery disease market to restrict the growth of blood vessels and thus reduces the risk of a heart attack or stroke.
Application Insights:
Based on application, the market is segmented into hospitals, ambulatory surgery centers, drug eluting stents for coronary artery disease treatment, catheterization laboratories and others. The other segment includes research institutes and clinical trials. In 2017, the hospital application dominated with a share of over 80%. This can be attributed to factors such as availability of advanced healthcare facilities along with highly skilled personnel in large hospitals.
Drug eluting stents are used for treating various diseases such as diabetes mellitus type 2 & 1 (coronary artery disease), hypertension (high cholesterol) & heart failure (low blood flow to the heart), stroke prevention during pregnancy & after 40 years of age etc. Thus rising prevalence of target diseases coupled with increasing awareness about effective treatment options is expected to drive demand from ambulatory surgery centers and catheterization laboratories over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the local presence of major players and high adoption of advanced technologies. Moreover, increasing prevalence of diabetes is expected to fuel demand for ADEBs in this region. According to CDC, around 29 million people have diabetes and this number is growing rapidly every year. In addition, favorable reimbursement policies are also boosting usage rates of these products in North America.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rising healthcare expenditure by governments as well as private organizations coupled with improving healthcare infrastructure & services offered by hospitals & ambulatory surgery centers (ASC). Rising incidence rate of cardiovascular diseases such as stroke and peripheral artery disease will further drive regional growth during the forecast period.
Growth Factors:
- Increasing incidence of peripheral artery disease (PAD) due to growing aging population and rising prevalence of risk factors such as obesity, smoking, and diabetes.
- Growing demand for minimally invasive procedures for the treatment of PAD.
- Technological advancements in drug eluting balloon technology that offer improved clinical outcomes over traditional angioplasty procedures.
- Rising healthcare expenditure and increasing insurance coverage for PAD treatments will boost the growth of the drug eluting balloon market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Eluting Balloon for Peripheral Artery Disease Market Research Report
By Type
3?g/ mm2, 2?g/ mm2, Others
By Application
Hospitals, Ambulatory Surgery Centers, Catheterization Laboratories, Others
By Companies
Cook Group, BD, Medtronic, Bayer, Opto Circuits
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Drug Eluting Balloon for Peripheral Artery Disease Market Report Segments:
The global Drug Eluting Balloon for Peripheral Artery Disease market is segmented on the basis of:
Types
3?g/ mm2, 2?g/ mm2, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgery Centers, Catheterization Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cook Group
- BD
- Medtronic
- Bayer
- Opto Circuits
Highlights of The Drug Eluting Balloon for Peripheral Artery Disease Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 3?g/ mm2
- 2?g/ mm2
- Others
- By Application:
- Hospitals
- Ambulatory Surgery Centers
- Catheterization Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Eluting Balloon for Peripheral Artery Disease Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A drug eluting balloon is a medical device that uses balloons to deliver drugs and other treatments to the peripheral artery. The balloons are filled with a medication or other treatment, and when they are inflated, the pressure causes the medication or treatment to flow through the balloon into the bloodstream. This allows it to reach areas of damage in the arteries more easily than traditional methods such as surgery or medications.
Some of the key players operating in the drug eluting balloon for peripheral artery disease market are Cook Group, BD, Medtronic, Bayer, Opto Circuits.
The drug eluting balloon for peripheral artery disease market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Eluting Balloon for Peripheral Artery Disease Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Eluting Balloon for Peripheral Artery Disease Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Eluting Balloon for Peripheral Artery Disease Market - Supply Chain
4.5. Global Drug Eluting Balloon for Peripheral Artery Disease Market Forecast
4.5.1. Drug Eluting Balloon for Peripheral Artery Disease Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Eluting Balloon for Peripheral Artery Disease Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug Eluting Balloon for Peripheral Artery Disease Market Absolute $ Opportunity
5. Global Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Type
5.3.1. 3?g/ mm2
5.3.2. 2?g/ mm2
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory Surgery Centers
6.3.3. Catheterization Laboratories
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug Eluting Balloon for Peripheral Artery Disease Demand Share Forecast, 2019-2026
9. North America Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory Surgery Centers
9.4.3. Catheterization Laboratories
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Type
9.7.1. 3?g/ mm2
9.7.2. 2?g/ mm2
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug Eluting Balloon for Peripheral Artery Disease Demand Share Forecast, 2019-2026
10. Latin America Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Catheterization Laboratories
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Type
10.7.1. 3?g/ mm2
10.7.2. 2?g/ mm2
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug Eluting Balloon for Peripheral Artery Disease Demand Share Forecast, 2019-2026
11. Europe Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Catheterization Laboratories
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Yo-Y Growth Projections by Application
11.7. Europe Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Type
11.7.1. 3?g/ mm2
11.7.2. 2?g/ mm2
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug Eluting Balloon for Peripheral Artery Disease Demand Share, 2019-2026
12. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Catheterization Laboratories
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Type
12.7.1. 3?g/ mm2
12.7.2. 2?g/ mm2
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Demand Share, 2019-2026
13. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Catheterization Laboratories
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Market Size and Volume Forecast by Type
13.7.1. 3?g/ mm2
13.7.2. 2?g/ mm2
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Market Share Analysis
14.2. Drug Eluting Balloon for Peripheral Artery Disease Distributors and Customers
14.3. Drug Eluting Balloon for Peripheral Artery Disease Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cook Group
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BD
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medtronic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Opto Circuits
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
